How can sustainable manufacturing impact the environment? Biogen’s manufacturing group finds ways to reduce, reuse and recycle throughout the creation of a new medicine.

VIDEO TRANSCRIPT:

The world we know is threatened by pollution, loss of biodiversity, and a lack of resources - according to the American Chemical Society, an estimated 44 elements will face supply limitations in the coming years with some becoming challenging to access within 100 years.

Each one of us needs to do our part when it comes to taking care of the planet - reduce, reuse, recycle.

Individuals, private companies, communities, and countries can all have an impact.

Preserving the world's resources effect not only the health of the environment but the health of future generations.

At Biogen, we’re employing innovative, sustainable processes to actively reduce waste and minimize use of natural resources and energy.

These principles form the basis of green chemistry.

Producing a medicine involves the combination of a number of different ingredients across many steps; Biogen scientists are looking at the entire production process, finding ways to reduce the number of steps – creating new, more efficient, less wasteful, methods.

By using flow chemistry in our production process we are reducing the energy needed to reach the low temperatures required to create certain new medicines.

Beyond conserving energy, it's also about resources. Some of the ingredients that go into making a medicine are ubiquitous, while other ingredients are quite rare - so rare, in fact, that accessing them may become difficult in the next 50 years.

To conserve these resources, we utilize techniques that allow us to recycle and reprocess the elements needed in the production of medicines.

For example, we’ve initiated the use of packed-bed flow reactors to recover the catalyst in some reactions, allowing them to be reused after production completes.

These resources are finite - we must do our part to preserve them and the environment.

Biogen was the first company in the life sciences industry to become carbon neutral in 2014, and, by 2030, all of our products will achieve greater than 90% of our green chemistry targets - reducing waste at every step of the manufacturing process.

Still, we’re looking beyond even that – our aim is to go ‘beyond net zero’ – by way of our Healthy Climate, Healthy Lives initiative, a 20 year, 250 million dollar investment back into our planet to become fossil fuel free.

The changes that each of us make will shape our planet for future generations - Biogen is committed to this future. Join us as we strive toward building a stronger, more sustainable world for all.

Learn more about Healthy Climate, Healthy Lives

Biogen

Biogen

Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

More from Biogen